Chandra Praveen
Latest contributions
Global momentum of Shockwave intravascular lithotripsy: evidence, experience and evolution
11 Dec 2025 – From GulfPCR-GIM 2025
This session examines the growing global experience in the treatment of calcified coronary lesions, bringing together updated clinical evidence and real-world practice.
Recent data are discussed alongside insights from high-volume operators to show how calcium modification strategies are evolving and being integrated into contemporary PCI workflows.
By combining...
Hotline TAVI 3: Challenging anatomical and clinical scenarios
22 May 2025 – From EuroPCR 2025
This hotline session presents challenging anatomical and clinical scenarios in TAVI, including outcomes in bicuspid aortic valve patients, chronic aortic regurgigation, comparisons of surgical versus percutaneous approaches, and real-world data on valve performance and resource utilization.
Inludes:
- Five-year outcomes from the Evolut low risk TAVR bicuspid study
- Surgical versus...
Treating complex CAD indications with sirolimus coated balloon: evidence and performance
22 May 2025 – From EuroPCR 2025
Gain a deeper understanding of how sirolimus coated balloon (SCB) technology is shaping the treatment of complex coronary artery disease (CAD). This EuroPCR 2025 session brings together compelling clinical trial data and real-world case presentations to illustrate the safety, efficacy, and versatility of the MagicTouch SCB...
New tools for left main treatment
21 May 2025 – From EuroPCR 2025
Examine new tools and strategies tailored for left main coronary artery treatment. This session covers real-world data on intracoronary imaging guidance, post-PCI FFR assessment following provisional T stenting, safety and efficacy of intravascular lithotripsy for calcified left main disease, drug-coated balloon (DCB) treatments for true bifurcation...
PCI with BRS
17 May 2023 – From EuroPCR 2023
Looking to enhance your expertise in percutaneous coronary intervention using a bioresorbable scaffold? Join your collegues for a series of case presentations where you can observe different strategies in complicated situations.
Ultra-thin strut stenting to manage challenges in STEMI
17 May 2023 – From EuroPCR 2023
Dilip Kumar and Praveen Chandra discuss the issues and nuances in the treatment of ST-segment elevation myocardial infarction, with a particular focus on the use of ultra-thin strut stents in the treatment of primary angioplasty, or primary STEMI treatment.
After reviewing the situation in India, they take...
Left main bifurcation treatment with Ultrathin Supraflex Cruz stent: from non-invasive angiography to invasive assessment of anatomy and physiology
16 May 2023 – From EuroPCR 2023
In this session, experience a multimodality approach, including CTA, angiography and OCT, and learn how to reestablish good hemodynamic of the bifurcation, by analyzing the case of an 81-year-old man with no risk factors, no relevant comorbidities, and no treatment, who presented with crescendo effort angina.
EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in drug-eluting balloons! A Sirolimus-coated balloon with micro-reservoir technology in coronary lesions, utilisation of DEB guided by post-PCI pressure gradient, DEB in combination with DES in the treatment of diffuse coronary artery disease,DEB for in-stent restenosis and plaque...
Sirolimus coated balloon and coronary artery disease: expanding the treatment indications
17 May 2022 – From EuroPCR 2022
Through a case presentation, as well as upcoming studies and rationale for the Food and Drug Administration, the aim of this EuroPCR 2022 session is to help you answer the following questions: how can the use of a sirolimus-coated DCB be expanded in new and challenging treatment indications? Why is...
Mechanical circulatory support: which, how, when!
09 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session to learn more about the use of mechanical circulatory support in cardiogenic shock and high-risk PCI, the selection of MCS depending on the patient, as well as the strategy of PCI in cardiogenic shock.
